SCHEMBL23539697

SCHEMBL23539697

NNC(=O)Nc1ccc(Cl)cn1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.79
PTK2 Q05397 1/20 0.64
RAB9A P51151 10/20 0.60
SMN1; SMN2 Q16637 5/20 0.60
KMT2A Q03164 3/20 0.60
MAPT P10636 2/20 0.60
LMNA P02545 1/20 0.60
NPC1 O15118 7/20 0.59
MEN1 O00255 2/20 0.59
TDP1 Q9NUW8 1/20 0.57
BRD4 O60885 1/20 0.55
TSHR P16473 2/20 0.54
TP53 P04637 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
ALDH1A1 P00352 2/20 0.54
GLA P06280 1/20 0.51
MAPK1 P28482 1/20 0.51
ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032454 0.81 L3MBTL1 (0.72) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL24654650 0.81 L3MBTL1 (0.78) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL4124368 0.79 L3MBTL1 (0.75) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL23565515 0.79 RAB9A (0.53) L3MBTL1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL20639917 0.79 L3MBTL1 (0.49) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL25160800 0.79 RAB9A (0.68) L3MBTL1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL2632202 0.79 L3MBTL1 (0.68) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL27596585 0.78 L3MBTL1 (0.72) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL17151535 0.78 L3MBTL1 (0.72) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A
SCHEMBL27578720 0.78 L3MBTL1 (0.77) L3MBTL1PTK2RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127459-A1 GPR139 RECEPTOR MODULATORS BLACKTHORN THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed
WO-2021127459-A1 GPR139 RECEPTOR MODULATORS BLACKTHORN THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed